文献速递免疫规划

表达禽腺病毒血清4型纤维蛋白2的重组新城疫病毒疫苗对鸡肝炎-心包积液综合征和新城疫的保护

Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype 4 fiber-2 protein.
PubMed 文献 · Vaccine · 2020-01-14

本研究利用反向遗传技术构建表达禽腺病毒血清4型(FAdV-4)纤维蛋白2基因的重组新城疫病毒(NDV)LaSota疫苗株(rLaSota-fiber2),以2周龄SPF白来航鸡单剂量肌内注射活疫苗或灭活疫苗,两者均完全保护抵抗强毒NDV攻击;活疫苗对强毒FAdV-4攻击的保护优于灭活疫苗并显著减少粪便排毒。

要点

  • rLaSota-fiber2遗传稳定,在鸡胚中生长特性与亲本rLaSota病毒相当。
  • 单剂量肌内注射活或灭活rLaSota-fiber2均完全保护抵抗强毒NDV攻击。
  • 活疫苗对强毒FAdV-4攻击的保护优于灭活疫苗,并显著减少粪便排毒。

核心结论

  • NDV载体FAdV-4疫苗是同时防控肝炎-心包积液综合征和新城疫的有前景的二价疫苗候选。

研究设计与样本

  • 利用反向遗传技术构建表达FAdV-4纤维蛋白2全长基因的重组NDV LaSota疫苗株(rLaSota-fiber2),以2周龄SPF白来航鸡进行单剂量肌内注射活疫苗或灭活疫苗的免疫效力评价。

主要发现

  • rLaSota-fiber2遗传稳定,在鸡胚中生长特性与亲本rLaSota病毒相当。
  • 单剂量肌内注射2周龄SPF白来航鸡活或灭活rLaSota-fiber2均完全保护抵抗强毒NDV攻击。
  • 单剂量肌内注射活rLaSota-fiber2对强毒FAdV-4攻击的保护优于灭活疫苗,并较灭活疫苗显著减少粪便排毒。

局限性

  • 本研究的未发表数据显示,活rLaSota-fiber2经饮水或点眼接种不能产生对强毒FAdV-4攻击的保护,因此本研究采用肌内注射途径评价效力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Newcastle disease (ND) is one of the most important and devastating avian diseases with considerable threat to the global poultry industry. Hepatitis-hydropericardium syndrome (HHS), caused by virulent fowl adenovirus serotype 4 (FAdV-4), is another highly infectious disease in chickens with severe economic impact. The effective way to combat ND and HHS is by vaccinating the poultry. In the present study, a recombinant NDV LaSota vaccine strain expressing full length fiber-2 gene of FAdV-4 (rLaSota-fiber2) was generated using reverse genetics. The FAdV-4 fiber-2 protein was expressed as a soluble form rather than NDV membrane-anchored form. The rLaSota-fiber2 was genetically stable, and it showed growth patterns in embryonated eggs comparable to that of parental rLaSota virus. Since our unpublished data demonstrated that delivery of live rLaSota-fiber2 in drinking water or ocular delivery of the vaccine didn't produce protection against hypervirulent FAdV-4 challenge, even though the vaccine provide full protection against NDV challenge, the efficacy of the rLaSota-fiber2 was evaluated by delivering the vaccine intramuscularly in this study. Single-dose intramuscular vaccination of 2-week-old SPF White Leghorn chicks with the live or inactivated rLaSota-fiber2 provided complete protection against virulent NDV challenge. However, single-dose intramuscular vaccination with the live rLaSota-fiber2 vaccine provided better protection against virulent FAdV-4 challenge and significantly reduced faecal viral shedding comparing to the inactivated vaccine. These results indicate that the NDV-vectored FAdV-4 vaccine is a promising bivalent vaccine candidate to control both HHS and ND.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tian KY, Guo HF, Li N, et al. Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype 4 fiber-2 protein. Vaccine. 2020. PMID: 31948818. doi:10.1016/j.vaccine.2020.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。